Tremfya on The Journal.

The Journal.May 22, 2026

How YouTube Took Over the American Classroom

0:37
mid-roll
Kate Linebaugh, Ryan Knutson
The Wall Street Journal & Spotify Studios
May 22, 2026
UnknownBrand awarenessBaked-in adHealthcare
0:00 / 0:37
@ 14:16 in ep

Estimated current placement value

Low confidence
~$960range $180$6,600

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 200 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:37 · Unknown · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremfya offers self injection or intravenous infusion from the start. Tremfya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremfya, proper training is required. Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis.

Auto-transcribed · verbatim audio matches · Report an error

More from this campaign

Tremfya Campaign 1

3 promos

More from Tremfya

Recent reads from this sponsor outside this campaign

4 promos
Part of campaign

Tremfya Campaign 1

Tremfya is a prescription medicine for adults with moderately to severely active Crohn's disease and ulcerative colitis, offering self-injection or intravenous infusion.

4 promos·3 shows

Episode

The Journal.
How YouTube Took Over the American Classroom
Hosts: Kate Linebaugh, Ryan Knutson
Publisher: The Wall Street Journal & Spotify Studios